Pleural Diseases Market Expansion Outlook: $6.88 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Pleural Diseases Market Between 2025 And 2029?

The pleural diseases market has experienced robust growth in recent years. This market is projected to expand from $4.86 billion in 2024 to $5.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historic period can be attributed to the rising incidence of pleural effusion, growing awareness regarding pleural diseases, an increasing focus on early diagnosis, a growing number of healthcare facilities, and a rising number of pleural disease clinical trials.

The pleural diseases market is projected to experience substantial expansion over the upcoming years, with its valuation expected to reach $6.88 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from several factors, including an increase in the prevalence of pleural diseases, an expanding aging population, a rise in occupational hazards, an uptick in clinical trials, and a proliferation of diagnostic centers. Key developments shaping this period encompass progress in diagnostics, enhanced diagnostic tools, the implementation of minimally invasive procedures, improvements in drug development, and the increasing embrace of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Are The Drivers Pushing New Developments In The Pleural Diseases Market?

The rising occurrence of infectious diseases is anticipated to propel the expansion of the pleural diseases market in the future. These diseases are health conditions stemming from detrimental microorganisms like bacteria, viruses, fungi, or parasites. Shifts in human behavior due to environmental factors and progress in worldwide travel contribute to the growing frequency of infectious diseases. Conditions like bacterial pneumonia, tuberculosis, or viral infections, which are infectious diseases, are capable of inducing pleural disease through the stimulation of inflammation, infection, or the buildup of fluid within the pleural cavity. As an illustration, in January 2023, data from the National Library of Medicine, a US-based medical library for research and information, indicated that infectious diseases are responsible for more than 52 million deaths each year, endangering half of the global population. Moreover, around 14 million children under the age of five perish annually, and 70% of these fatalities are linked to illnesses preventable by vaccination. Consequently, the growing incidence of infectious diseases stimulates the expansion of the pleural diseases market.

What Are The Different Segment Classifications Within The Pleural Diseases Market?

The pleural diseasesmarket covered in this report is segmented –

1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types

2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy

4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis

How Are Trends Influencing The Pleural Diseases Market?

Leading companies in the pleural diseases market are concentrating on creating innovative treatment options, such as the development of ready-to-use injectable treatments, to enhance convenience, decrease preparation time, and reduce dosing errors. These ready-to-use injectable treatments are pre-formulated, pre-diluted medications that do not require reconstitution or mixing before administration, thereby ensuring accuracy, ease of use, and reduced preparation time. For example, in April 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, unveiled PEMRYDI RTU, which is the first ready-to-use version of pemetrexed for injection. This development assists patients with pleural diseases by offering a convenient, pre-prepared treatment that eliminates the need for reconstitution or dilution, shortens preparation time, minimizes the likelihood of dosing errors, and improves access to effective therapy for conditions like malignant pleural mesothelioma.

Which Global Market Leaders Are Shaping The Future Of The Pleural Diseases Sector?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Geographies Are Emerging As Strong Markets For The Pleural Diseases Industry?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pleural Diseases Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795